Clinical Trial Update: A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 study comparing epoetin alfa to placebo in patients with persistent anemia caused by advanced cancer to evaluate safety and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Phase 2 | Status: COMPLETED